Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Nephrology Drugs Market?

In the past few years, the nephrology drugs market has seen a consistent growth. It is set to expand from a size of $16.88 billion in 2024 to $17.69 billion in 2025, with a 4.8% compound annual growth rate (CAGR). The past growth trends can be attributed to factors such as a rise in chronic kidney diseases (CKD), advancements in the development of nephrology drugs, heightened awareness and diagnosis rates, government interventions and healthcare policies, and an increasing occurrence of diabetes.

In the forthcoming years, the market size for nephrology drugs is anticipated to experience robust growth. The market is projected to reach $22.61 billion in 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.3%. The expansion in the forecast period is predicted due to the development of novel therapies and drugs, precision medicine, personalized approach to treatment, growing expenditure in healthcare, the utilization of telehealth and remote patient monitoring, as well as global health initiatives. The forecast period also exhibits major trends including partnerships and collaborations, technological progression in dialysis, improvements in treatment modalities, an increasing focus on early diagnosis and intervention, and technological incorporation in managing nephrology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10076&type=smp

Which Factor Is Shaping The Future Of The Nephrology Drugs Market?

The increase in cases of chronic kidney disease (CKD) is projected to spur the expansion of the nephrology drugs market. CKD is a condition that impairs the kidneys’ blood filtration ability due to damage that happens gradually over time. This slow deterioration can result in waste accumulation in the body. To slow down this progression and enhance kidney function, nephrology drugs are used, thus contributing to the growth of the nephrology drug market. For example, reports by the Centers for Disease Control and Prevention (CDC), a health protection agency based in the US, in July 2022, revealed an estimated 37 million individuals in the US diagnosed with chronic kidney disease. This disease is more prevalent amongst those who are 65 years or older, accounting for 38 percent. Likewise, the Kidney Foundation of Canada, a non-profit organization in Canada, states that 4 million Canadians are affected by kidney diseases, with 35 percent of kidney failure cases linked to diabetes patients. Such numbers are predicted to increase in the future, hence reinforcing the chronic kidney disease prevalence as a key driver for the nephrology drug market’s expansion.

What Is The Segment-Wise Breakdown Of The Nephrology Drugs Market?

The nephrology drugs market covered in this report is segmented –

1) By Drugs: Antihypertensive Agents, Erythropoiesis-Stimulating Agents, Diuretics, ACE Inhibitors, Antidiabetic Agents, Other Drugs

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Antihypertensive Agents: Calcium Channel Blockers, Beta-Blockers, Angiotensin II Receptor Blockers (ARBs)

2) By Erythropoiesis-Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa

3) By Diuretics: Loop Diuretics, Thiazide Diuretics, Potassium-Sparing Diuretics

4) By ACE Inhibitors: Lisinopril, Enalapril

5) By Antidiabetic Agents: Metformin, Insulin

6) By Other Drugs: Phosphate Binders, Vitamin D Analogues, Renin Inhibitors

Which Trends Are Redefining The Future Landscape Of The Nephrology Drugs Industry?

A significant trend emerging within the nephrology drug market is the emphasis on product innovation. Leading companies in this space are creating new products and pharmaceuticals to maintain their competitive edge. Take for example, Zydus Lifesciences Limited, an India-based pharmaceutical company, which in March 2022, unveiled a new drug called Oxemia (desidustat) for the treatment of chronic kidney disease (CKD). This oral drug is a small-molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor and offers a feasible therapeutic option for anemia, having been approved by the Drug Controller General of India in phase III clinical trials. It showed promising safety profiles, downregulation of hepcidin, enhanced iron mobilization, and a decrease in LDL-C in patients suffering from chronic kidney disease. Moreover, the drug is reasonably priced thereby enhancing patients’ quality of life and reducing the impact of this disease on their lives.

Which Companies Hold The Largest Market Share In The Nephrology Drugs Sector?

Major companies operating in the nephrology drugs market include AstraZeneca plc, AbbVie Inc., Akebia Therapeutics Inc., Amgen Inc., F. Hoffmann-La Roche AG, FibroGen Inc., Johnson And Johnson, Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Boehringer Ingelheim International GmbH, Reata Pharmaceuticals Inc., Ardelyx Inc., Novo Nordisk A/S, Novartis AG, Baxter International Inc., Bristol Myers Squibb Company, Kissei Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals, OPKO Health Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Vifor Pharma Group, Bayer AG, Amicus Therapeutics, Chugai Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Mylan N.V., Endo Pharmaceuticals plc

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report

How Does Regional Performance Compare Across The Nephrology Drugs Industry?

North America was the largest region in the nephrology drug market in 2024.Europe will be the second-largest growing region in the nephrology drug market in 2024. The regions covered in the nephrology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10076&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model